ORIGINAL PAPER: Renal functional reserve in obesity hypertension
The capacity to increase glomerular filtration rate in response to an acute oral protein load is known as the renal functional reserve; the loss of such capacity is used as a marker of hyperfiltration. This physiological response in obese hypertensives is not yet fully understood. We aimed to study...
Gespeichert in:
Veröffentlicht in: | International journal of clinical practice (Esher) 2006-10, Vol.60 (10), p.1198 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 10 |
container_start_page | 1198 |
container_title | International journal of clinical practice (Esher) |
container_volume | 60 |
creator | PECLY, I M D GENELHU, V FRANCISCHETTI, E A |
description | The capacity to increase glomerular filtration rate in response to an acute oral protein load is known as the renal functional reserve; the loss of such capacity is used as a marker of hyperfiltration. This physiological response in obese hypertensives is not yet fully understood. We aimed to study the interdependent effects of obesity and hypertension on renal reserve, taking into account renal kallikrein and nitric oxide in the modulation of that parameter. Fourteen obese hypertensives (mean age, 50.5 +- 0.9 years) and nine lean hypertensives (mean age, 50.6 +- 2.7 years) were evaluated. Renal haemodynamics and the levels of serum nitric oxide and urinary kallikrein were assessed at baseline and after a protein load (1 g/kg of body weight). An increase in the following parameters was observed when comparing obese and lean hypertensives: basal glomerular filtration rate; renal plasma flow; and urinary kallikrein and nitric oxide levels (129.2 +- 2.9 vs. 101.4 +-_3.4 ml/min/1.73 m2; 587.5 +- 18.2 vs. 502.8 +- 16.7 ml/min/1.73 m2; 0.120 +- 0.02 vs. 0.113 +- 0.02 mU/ml; 23.2 +- 0.8 vs. 19.5 ± 1.2 mmol/ml, respectively). The renal reserve was lower in obese hypertensives when compared with that of lean hypertensives (4.1 +- 0.5 vs. 11.8 +- 0.8 ml/min, p < 0.005). After a protein load, contrasting with the lean group, inability to elevate the nitric oxide serum levels and a lower increase in urinary kallikrein were observed in the obese group. These data suggest that obese hypertensives lose renal reserve earlier in the evolution to renal dysfunction. This may be due to the defective modulation of renal vasodilatation mechanisms by renal kallikrein and nitric oxide production. [PUBLICATION ABSTRACT] |
doi_str_mv | 10.1111/j.1742-1241.2006.01037.x |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_229915349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1125489111</sourcerecordid><originalsourceid>FETCH-proquest_journals_2299153493</originalsourceid><addsrcrecordid>eNpjYFAwNNAzBAL9LD1DcxMjXUMjE0M9IwMDMz0DQwNjc70KJgZOuAQLkG1sZqFramBsyMHAVVycZWBgZGpqYcDJwOcf5Onu6efooxDgGOAaxMPAmpaYU5zKC6W5GZTcXEOcPXQLivILS1OLS-Kz8kuL8oBS8UZGlpaGpsYmlsZEKQIAkwIsbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229915349</pqid></control><display><type>article</type><title>ORIGINAL PAPER: Renal functional reserve in obesity hypertension</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>PECLY, I M D ; GENELHU, V ; FRANCISCHETTI, E A</creator><creatorcontrib>PECLY, I M D ; GENELHU, V ; FRANCISCHETTI, E A</creatorcontrib><description>The capacity to increase glomerular filtration rate in response to an acute oral protein load is known as the renal functional reserve; the loss of such capacity is used as a marker of hyperfiltration. This physiological response in obese hypertensives is not yet fully understood. We aimed to study the interdependent effects of obesity and hypertension on renal reserve, taking into account renal kallikrein and nitric oxide in the modulation of that parameter. Fourteen obese hypertensives (mean age, 50.5 +- 0.9 years) and nine lean hypertensives (mean age, 50.6 +- 2.7 years) were evaluated. Renal haemodynamics and the levels of serum nitric oxide and urinary kallikrein were assessed at baseline and after a protein load (1 g/kg of body weight). An increase in the following parameters was observed when comparing obese and lean hypertensives: basal glomerular filtration rate; renal plasma flow; and urinary kallikrein and nitric oxide levels (129.2 +- 2.9 vs. 101.4 +-_3.4 ml/min/1.73 m2; 587.5 +- 18.2 vs. 502.8 +- 16.7 ml/min/1.73 m2; 0.120 +- 0.02 vs. 0.113 +- 0.02 mU/ml; 23.2 +- 0.8 vs. 19.5 ± 1.2 mmol/ml, respectively). The renal reserve was lower in obese hypertensives when compared with that of lean hypertensives (4.1 +- 0.5 vs. 11.8 +- 0.8 ml/min, p < 0.005). After a protein load, contrasting with the lean group, inability to elevate the nitric oxide serum levels and a lower increase in urinary kallikrein were observed in the obese group. These data suggest that obese hypertensives lose renal reserve earlier in the evolution to renal dysfunction. This may be due to the defective modulation of renal vasodilatation mechanisms by renal kallikrein and nitric oxide production. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 1368-5031</identifier><identifier>EISSN: 1742-1241</identifier><identifier>DOI: 10.1111/j.1742-1241.2006.01037.x</identifier><language>eng</language><publisher>London: Hindawi Limited</publisher><subject>Hypertension ; Kidney diseases ; Medical research ; Nephrology ; Nitric oxide ; Obesity</subject><ispartof>International journal of clinical practice (Esher), 2006-10, Vol.60 (10), p.1198</ispartof><rights>2006 The Authors Journal compilation 2006 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>PECLY, I M D</creatorcontrib><creatorcontrib>GENELHU, V</creatorcontrib><creatorcontrib>FRANCISCHETTI, E A</creatorcontrib><title>ORIGINAL PAPER: Renal functional reserve in obesity hypertension</title><title>International journal of clinical practice (Esher)</title><description>The capacity to increase glomerular filtration rate in response to an acute oral protein load is known as the renal functional reserve; the loss of such capacity is used as a marker of hyperfiltration. This physiological response in obese hypertensives is not yet fully understood. We aimed to study the interdependent effects of obesity and hypertension on renal reserve, taking into account renal kallikrein and nitric oxide in the modulation of that parameter. Fourteen obese hypertensives (mean age, 50.5 +- 0.9 years) and nine lean hypertensives (mean age, 50.6 +- 2.7 years) were evaluated. Renal haemodynamics and the levels of serum nitric oxide and urinary kallikrein were assessed at baseline and after a protein load (1 g/kg of body weight). An increase in the following parameters was observed when comparing obese and lean hypertensives: basal glomerular filtration rate; renal plasma flow; and urinary kallikrein and nitric oxide levels (129.2 +- 2.9 vs. 101.4 +-_3.4 ml/min/1.73 m2; 587.5 +- 18.2 vs. 502.8 +- 16.7 ml/min/1.73 m2; 0.120 +- 0.02 vs. 0.113 +- 0.02 mU/ml; 23.2 +- 0.8 vs. 19.5 ± 1.2 mmol/ml, respectively). The renal reserve was lower in obese hypertensives when compared with that of lean hypertensives (4.1 +- 0.5 vs. 11.8 +- 0.8 ml/min, p < 0.005). After a protein load, contrasting with the lean group, inability to elevate the nitric oxide serum levels and a lower increase in urinary kallikrein were observed in the obese group. These data suggest that obese hypertensives lose renal reserve earlier in the evolution to renal dysfunction. This may be due to the defective modulation of renal vasodilatation mechanisms by renal kallikrein and nitric oxide production. [PUBLICATION ABSTRACT]</description><subject>Hypertension</subject><subject>Kidney diseases</subject><subject>Medical research</subject><subject>Nephrology</subject><subject>Nitric oxide</subject><subject>Obesity</subject><issn>1368-5031</issn><issn>1742-1241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpjYFAwNNAzBAL9LD1DcxMjXUMjE0M9IwMDMz0DQwNjc70KJgZOuAQLkG1sZqFramBsyMHAVVycZWBgZGpqYcDJwOcf5Onu6efooxDgGOAaxMPAmpaYU5zKC6W5GZTcXEOcPXQLivILS1OLS-Kz8kuL8oBS8UZGlpaGpsYmlsZEKQIAkwIsbQ</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>PECLY, I M D</creator><creator>GENELHU, V</creator><creator>FRANCISCHETTI, E A</creator><general>Hindawi Limited</general><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20061001</creationdate><title>ORIGINAL PAPER</title><author>PECLY, I M D ; GENELHU, V ; FRANCISCHETTI, E A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2299153493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Hypertension</topic><topic>Kidney diseases</topic><topic>Medical research</topic><topic>Nephrology</topic><topic>Nitric oxide</topic><topic>Obesity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PECLY, I M D</creatorcontrib><creatorcontrib>GENELHU, V</creatorcontrib><creatorcontrib>FRANCISCHETTI, E A</creatorcontrib><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>International journal of clinical practice (Esher)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PECLY, I M D</au><au>GENELHU, V</au><au>FRANCISCHETTI, E A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ORIGINAL PAPER: Renal functional reserve in obesity hypertension</atitle><jtitle>International journal of clinical practice (Esher)</jtitle><date>2006-10-01</date><risdate>2006</risdate><volume>60</volume><issue>10</issue><spage>1198</spage><pages>1198-</pages><issn>1368-5031</issn><eissn>1742-1241</eissn><abstract>The capacity to increase glomerular filtration rate in response to an acute oral protein load is known as the renal functional reserve; the loss of such capacity is used as a marker of hyperfiltration. This physiological response in obese hypertensives is not yet fully understood. We aimed to study the interdependent effects of obesity and hypertension on renal reserve, taking into account renal kallikrein and nitric oxide in the modulation of that parameter. Fourteen obese hypertensives (mean age, 50.5 +- 0.9 years) and nine lean hypertensives (mean age, 50.6 +- 2.7 years) were evaluated. Renal haemodynamics and the levels of serum nitric oxide and urinary kallikrein were assessed at baseline and after a protein load (1 g/kg of body weight). An increase in the following parameters was observed when comparing obese and lean hypertensives: basal glomerular filtration rate; renal plasma flow; and urinary kallikrein and nitric oxide levels (129.2 +- 2.9 vs. 101.4 +-_3.4 ml/min/1.73 m2; 587.5 +- 18.2 vs. 502.8 +- 16.7 ml/min/1.73 m2; 0.120 +- 0.02 vs. 0.113 +- 0.02 mU/ml; 23.2 +- 0.8 vs. 19.5 ± 1.2 mmol/ml, respectively). The renal reserve was lower in obese hypertensives when compared with that of lean hypertensives (4.1 +- 0.5 vs. 11.8 +- 0.8 ml/min, p < 0.005). After a protein load, contrasting with the lean group, inability to elevate the nitric oxide serum levels and a lower increase in urinary kallikrein were observed in the obese group. These data suggest that obese hypertensives lose renal reserve earlier in the evolution to renal dysfunction. This may be due to the defective modulation of renal vasodilatation mechanisms by renal kallikrein and nitric oxide production. [PUBLICATION ABSTRACT]</abstract><cop>London</cop><pub>Hindawi Limited</pub><doi>10.1111/j.1742-1241.2006.01037.x</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1368-5031 |
ispartof | International journal of clinical practice (Esher), 2006-10, Vol.60 (10), p.1198 |
issn | 1368-5031 1742-1241 |
language | eng |
recordid | cdi_proquest_journals_229915349 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Hypertension Kidney diseases Medical research Nephrology Nitric oxide Obesity |
title | ORIGINAL PAPER: Renal functional reserve in obesity hypertension |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A07%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ORIGINAL%20PAPER:%20Renal%20functional%20reserve%20in%20obesity%20hypertension&rft.jtitle=International%20journal%20of%20clinical%20practice%20(Esher)&rft.au=PECLY,%20I%20M%20D&rft.date=2006-10-01&rft.volume=60&rft.issue=10&rft.spage=1198&rft.pages=1198-&rft.issn=1368-5031&rft.eissn=1742-1241&rft_id=info:doi/10.1111/j.1742-1241.2006.01037.x&rft_dat=%3Cproquest%3E1125489111%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229915349&rft_id=info:pmid/&rfr_iscdi=true |